Back to Search Start Over

Clinical profile and surgical outcome of pars plana vitrectomy in non-diabetic vitreous hemorrhage.

Authors :
Shrestha R
Shah RK
Joshi P
Parajuli S
Source :
Therapeutic advances in ophthalmology [Ther Adv Ophthalmol] 2022 Apr 12; Vol. 14, pp. 25158414221083366. Date of Electronic Publication: 2022 Apr 12 (Print Publication: 2022).
Publication Year :
2022

Abstract

Background: Spontaneous vitreous hemorrhage is one of the common causes of ocular emergency. There are very few prospective studies on the clinical profile and surgical outcomes for patients with dense vitreous hemorrhage caused by non-diabetic and non-traumatic till date to our knowledge.<br />Objectives: This study was conducted to better understand the etiologies, clinical profile, surgical outcome, and visual prognosis following pars plana vitrectomy for dense vitreous hemorrhage in adults with non-traumatic and non-diabetic retinopathy.<br />Design: This was a prospective interventional study.<br />Methods: This study was conducted in Mechi Eye Hospital (Birtamod, Nepal) from October 2018 to September 2019. All consecutive cases, 46 eyes of 46 patients, with vitreous hemorrhage that underwent vitrectomy were included in our study. There were 14 (30.4%) female and 32 (69.6%) male patients, and the average age at presentation was 43.74 ± 16.19 (17-84) years. The success rate of surgery in terms of visual outcome was evaluated.<br />Results: The most common cause of vitreous hemorrhage was retinal vasculitis with fibrovascular changes and vascular sheathing 19 (41%). The indication of vitrectomy on patient demand was 20 (43.5%). Success rate of surgery in terms of visual outcome (functional outcome) was defined as final visual acuity of >6/60 which was 86.9%.<br />Conclusion: The most common cause of spontaneous vitreous hemorrhage in our study was retinal vasculitis with fibrovascular changes and vascular sheathing. Vitrectomy has a good surgical outcome for spontaneous vitreous hemorrhage in terms of visual outcome (functional outcome) unless guarded by other factors like chorioretinal atrophy followed by optic atrophy and epiretinal membrane.<br />Competing Interests: Conflict of interest statement: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.<br /> (© The Author(s), 2022.)

Details

Language :
English
ISSN :
2515-8414
Volume :
14
Database :
MEDLINE
Journal :
Therapeutic advances in ophthalmology
Publication Type :
Academic Journal
Accession number :
35434519
Full Text :
https://doi.org/10.1177/25158414221083366